Today on DrugResearcher.com
 
BMS reveals plans to trim the fat

Morphosys to exit fee-for-service upon Novartis deal

Microfluidics promises a bright future for cell-based assays

Separating mixtures in an NMR machine

Drugs moving into the clinic: 38

 
   
Related Industry News
 
Abbott cuts jobs, closes plant in Ireland

Eisai selects Singapore as Asia trials hub

Arius and Avid team up

Combo products need guidelines

 
 

Drug discovery

Breaking News on Drug Discovery
Daily  Thursday 06 December 2007 Forward to a colleague

Sponsored Link

Hach Lange France / Radiometer AnalyticalExcellent value for money for routine moisture determination

The TitraLab 580 and 585 Volumetric Karl Fischer Workstations are ideal for fast and accurate moisture determination whether you are working with solids or liquids. Operation is simple thanks to pre-programmed functions and dedicated buttons for solvent addition and cell... Click Here

Access Full Stories



BMS reveals plans to trim the fat
Bristol-Myers Squibb (BMS) has finally detailed its plans to trim the fat and save cash, months after first revealing that big changes would be on the cards... Read


Morphosys to exit fee-for-service upon Novartis deal
Morphosys has landed in the money after scoring a lucrative 10 year antibody development deal with Novartis and as a result, will now place all its eggs in one basket and cut ties with its fee-for-service customers... Read


Microfluidics promises a bright future for cell-based assays
UK researchers have published results that show that microfluidic devices can provide robust quantitative pharmacological information from low numbers of single cells... Read


Separating mixtures in an NMR machine
Canadian researchers have devised a method of extracting the complete proton NMR (nuclear magnetic resonance) spectra for a component of a mixture without the need for physical separation... Read


Drugs moving into the clinic: 38
The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators... Read


All News Headlines for:
December | November | October

Fully autoclavable and Universal tip fittingSponsored Link

CappAero pipettes - ultimate accuracy and intelligent design

The cool transparent handle and dash of vibrant colour on the barrel ensures the ColorLine series will be a welcome addition to any laboratory. The distinctive colour of each pipette permits you to quickly identify the volume range of any pipette at a glance... Click Here

Related Industry News



Abbott cuts jobs, closes plant in Ireland
Abbott is to shut its doors on its Galway, Ireland, facility - taking 500 jobs with it - as the market moves into murky waters over the future of vascular stents... Read


Eisai selects Singapore as Asia trials hub
Eisai is planning to step up its clinical research presence in Asia and has chosen Singapore as a hub from which to coordinate its research activities... Read


Arius and Avid team up
Arius Research and Avid Bioservices have joined forces in the manufacturing and development of an anticancer antibody... Read


Combo products need guidelines
The combination products market is zooming ahead, requiring the need to address regulatory challenges, an author of a white paper says... Read

Weekly Comment

No embryo required: human stem cells from the skin

A startling breakthrough has allowed scientists to create human stem cells from just reprogrammed skin cells, with no embryo and thus, perhaps no ethical dilemma. Read



Previous Headlines



Addex and Merck target new cure for Parkinson's
Merck & Co. has entered into an exclusive collaboration and licensing deal with Addex Pharma to develop a new class of orally available Parkinson's therapies... Read


Drugs moving into the clinic: 37
The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators... Read


India's Glenmark pioneering through prioritising preclinical
Glenmark is one of a handful of pharma firms in India pushing forward a preclinical programme as a priority... Read


Pfizer plans more off-shoring and outsourcing
Pfizer is looking to Asia for both R&D and manufacturing outsourcing and to help it cut costs in a bid to mitigate the effects of patent expiries and competition from generic drugs... Read


Regeneron helps make Sanofi VelocImmune to its 'weak' pipeline
Sanofi-Aventis recently admitted it needed to increase the number of biotech compounds in its pipeline and now, true to its word, the French pharma heavyweight has signed a big antibody deal with US biotech Regeneron... Read

Technical / White Papers, Case studies, Web casts
Benefits of integrating human tissue research in drug discovery - Technical / White Paper

Manufacturing Variations in Polysorbate Batches - Technical / White Paper



Product Information - brochures, Web centers
DAICEL chiral chromatography products - Company Profile

Separation of polar compounds - Application Notes



Product Innovation Alerts - Free of Charge
Indicate your research interests and receive alerts on relevant products and market innovations
Analysis and instrumentation
Assays and screening
Cell culture & Equipment
Chromatography
Compounds and consumables
Contract services (outsourcing)
Drug discovery
Genomics / Proteomics
Informatics & IT
Lab equipment & consumables
Liquid handling and automation
Liquid handling and sample preparation
Production technologies
Separation and purification




Free Newsletters for Pharmaceuticals
Access now !Choose from over 20 industry e-newsletters
Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here

Forward to a colleague

To continue to receive this newsletter in your inbox, please add
newsletter@DrugResearcher.com to your address book

Update preferences | Change your email address | Unsubscribe

Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback

© 2007 - Decision News Media S.A.S - All Rights Reserved
Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France
http://www.decisionnewsmedia.com